BOSTON SCIENTIFIC $9.40

down -0.14


19/6/2013 04:19 PM  |  NYSE : BSX  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Last Trade: 9.40
Trade Time: Jun 19 4:06 PM Eastern Daylight Time
Change: -0.14 (-1.47 %)
Prev Close: 9.54
Open: 9.57
Bid: 9.40
Ask: 9.43
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get BSX Trend Analysis - it has outperformed the S&P 500 by 41%

ETF Alternatives



People viewing BSX also viewed: , , , ,

Competitors

Ticker Name Volume % Change
CPCF CPC OF AMERICA; INC. 1.6K +0.65%
RMCP REVOLUTIONS MEDICAL 789.2K +0.41%
DYXC DIASYS 20.0K +0.25%
SPHE SPEARHEAD LIMITED 55.0K +0.25%
CYOE CYTOCORE 54.8K +0.20%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
6/16/2013 CAPELLO JEFFREY D EVP & Chief Financial Officer -6,307 $9.51 -3.10%
5/31/2013 Mirviss Jeffrey B. SVP&Pres, Periph Intervent -2,071 $9.38 -2.88%
5/31/2013 Mirviss Jeffrey B. SVP&Pres, Periph Intervent -6,870 $9.36 -9.84%
5/31/2013 Mirviss Jeffrey B. SVP&Pres, Periph Intervent -2,000 $9.36 -2.71%
5/30/2013 Carruthers Wendy SVP, Human Resources -21,266 $9.16 -52.61%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (BSX), click here.
View All

BSX Stock Analysis

  1. BSX Commences U.S. INTREPID Trial - Analyst Blog

    (BSX,MDT,STJ,HAE )
    Boston Scientific initiates clinical trial for its Vercise DBS System in the U.S.
  2.

    St. Jude Expands Neuro Offerings - Analyst Blog

    (BSX,MDT,STJ,CYBX )
    St. Jude has entered into an exclusive distribution agreement with Spinal Modulation to sell its Axium Neurostimulator System in the global market.
  3.

    Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargain

    (MDT,BSX,STJ,JNJ )
    Medtronic continues to suffer with weak core markets, but business seems to be getting slowly better and valuation is not demanding
  4.

    Broad Weakness Makes It Harder To Like St. Jude Today

    (STJ,BSX,MDT,EW,JNJ,ATRC )
    Although I do believe the long-term expectations for St. Jude are increasingly beatable, this could be a frustrating stock to own for a little while yet.
Free Reports
  1.

    Trading Systems at No Cost

    Get a FREE Magazine on the Top 10 Trading Systems.
  2.

    Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
  3.

    Free Managed Futures Book

    Get the four benefits of managed futures as outlined in this booklet.
Marketplace
Trading Center